KYPROLIS
associated with 38 other trademarks
Human pharmaceuticals for use in the prevention of cancer, oncology, tumors, solid and hematological tumors and growths, hematological and hemolytic d...

Words that describe this trademark:

cancer oncology  human pharmaceuticals  prevention cancer  oncology  tumors  pharmaceuticals  growths  solid  hematological 

Serial Number:

85080817

Mark:

KYPROLIS

Status:

Abandoned-No Statement of Use filed

Status Date:

07-21-2014

Filing Date:

Registration Number:

N/A

Registration Date:

N/A

Goods and Services:

Human pharmaceuticals for use in the prevention of cancer, oncology, tumors, solid and hematological tumors and growths, hematological and hemolytic diseases and disorders, amyloidosis, metabolic diseases and disorders, lupus, and inflammation and autoimmune diseases and disorders; human pharmaceuticals for use in the treatment of solid tumors and growths, hemolytic diseases and disorders, amylodiosis, metabolic diseases and disorders, lupus, and inflammation and autoimmune diseases and disorders Pharmaceutical research and development; medical and scientific research, namely, conducting clinical trials; medical and scientific research in the fields of treatment for cancer and oncology, and in the fields of treatment of inflammation and autoimmune diseases

Mark Description:

N/A

Class:

Scientific and technological services

Type of Mark:

Trademark

Published for Opposition Date:

04-19-2011

Mark Drawing Status:

Standart Character Mark

Abandon Date:

07-21-2014

Business Name:

MARSHALL, GERSTEIN & BORUN LLP

Correspondent Name:

Recent Trademark filings by this company